Marinomed Biotech AG | WebDisclosure

BRIEF

published on 11/27/2024 at 07:50, 5 months 6 days ago

Marinomed Biotech AG vend sa division de carraghénane à Unither Pharmaceuticals

Marinomed Biotech AG Plan De Restructuration Plateforme Marinosolv Unither Pharmaceutique Vente De Carraghénose
BRIEF

published on 11/27/2024 at 07:50, 5 months 6 days ago

Marinomed Biotech AG to Sell Carragelose Business to Unither Pharmaceuticals

Marinomed Biotech AG Restructuring Plan Marinosolv Platform Carragelose Sale Unither Pharmaceuticals
PRESS RELEASE

published on 11/27/2024 at 07:45, 5 months 6 days ago

Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals
Marinomed Biotech AG signs agreement to sell Carragelose business to Unither Pharmaceuticals, generating up to EUR 20 million in proceeds for restructuring and investment

Restructuring Sale Agreement Marinomed Biotech AG Carragelose Unither Pharmaceuticals
BRIEF

published on 11/26/2024 at 21:19, 5 months 7 days ago

Marinomed Biotech AG accepte de vendre son activité de carraghélose à Unither Pharmaceuticals

Marinomed Biotech AG Plan De Restructuration Industrie Pharmaceutique Vente D'entreprise Unither Pharmaceutique
BRIEF

published on 11/26/2024 at 21:19, 5 months 7 days ago

Marinomed Biotech AG Agrees to Sell Carragelose Business to Unither Pharmaceuticals

Pharmaceutical Industry Marinomed Biotech AG Business Sale Restructuring Plan Unither Pharmaceuticals
PRESS RELEASE

published on 11/26/2024 at 21:14, 5 months 7 days ago

EQS-Adhoc: Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals
Marinomed Biotech AG signs agreement to sell Carragelose business to Unither Pharmaceuticals, facilitating refinancing and focus on Marinosolv. Agreement subject to various conditions

Refinancing Marinomed Biotech AG Marinosolv Unither Pharmaceuticals Carragelose Business
BRIEF

published on 11/14/2024 at 14:39, 5 months 19 days ago

Marinomed Biotech AG Secures Creditor Approval for Restructuring Plan

Insolvency Proceedings Marinomed Biotech AG Restructuring Plan Creditor Approval Carragelose Sale
BRIEF

published on 11/14/2024 at 14:39, 5 months 19 days ago

Marinomed Biotech AG obtient l'approbation des créanciers pour son plan de restructuration

Marinomed Biotech AG Plan De Restructuration Procédures D'insolvabilité Approbation Du Créancier Vente De Carraghénales
PRESS RELEASE

published on 11/14/2024 at 14:34, 5 months 19 days ago

EQS-Adhoc: Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
Marinomed Biotech AG announces unanimous approval of restructuring plan by creditors at final court hearing, involving sale of Carragelose business unit

Creditors Marinomed Biotech AG Restructuring Plan Court Hearing Carragelose Business Unit
BRIEF

published on 11/12/2024 at 07:50, 5 months 21 days ago

Marinomed Biotech AG révèle le succès clinique du spray nasal à base de carraghénane

Essais Cliniques Biotechnologie Marinomed Spray Nasal À La Carraghénane Rhinite Allergique Décongestionnant

Published on 05/03/2025 at 03:40, 18 hours 29 minutes ago

Snipp Interactive Announces Delay in Filing Audited Fiscal 2024 Financial Statements
Published on 05/03/2025 at 03:00, 19 hours 9 minutes ago

Vision Marine Technologies Inc. Announces Postponement of Annual Meeting of Shareholders
Published on 05/03/2025 at 02:06, 20 hours 3 minutes ago

Battery X Metals Achieves Pivotal Milestone with Delivery of Next-Generation Lithium-Ion Battery Rebalancing Machine and Announces Exclusive Live Reveal Event
Published on 05/02/2025 at 23:30, 22 hours 39 minutes ago

RE Royalties Announces Fiscal 2024 Year End Results and Highlights
Published on 05/02/2025 at 15:00, 1 day 7 hours ago

Newsmax #1 in Cable News for Key Demo Ratings Growth

View all ACCESSWIRE

Published on 05/03/2025 at 07:57, 14 hours 11 minutes ago

EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024
Published on 05/02/2025 at 19:00, 1 day 3 hours ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 05/02/2025 at 18:55, 1 day 3 hours ago

Avolta's Q1 Trading Update Invitation
Published on 05/02/2025 at 18:41, 1 day 3 hours ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 05/02/2025 at 18:30, 1 day 3 hours ago

Avolta's Full Year 2024 Results Invitation

View all EQS

Published on 05/02/2025 at 20:40, 1 day 1 hour ago

Rapport Financier Annuel 2024
Published on 05/02/2025 at 17:35, 1 day 4 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 04/30/2025 at 20:31, 3 days 1 hour ago

COMMUNIQUE DE PRESSE - RESULTATS 2024
Published on 04/30/2025 at 19:14, 3 days 2 hours ago

Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 3 days 2 hours ago

Solocal - Press Release - Filing of 2024 URD

View all LES ECHOS COMFI WIRE

News